Case Western Reserve University

IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board

Retrieved on: 
Friday, October 6, 2023

LAWRENCEVILLE, N.J., Oct. 06, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces the appointment of Patrick Ott, M.D., Ph.D. to the Company’s scientific advisory board.

Key Points: 
  • LAWRENCEVILLE, N.J., Oct. 06, 2023 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces the appointment of Patrick Ott, M.D., Ph.D. to the Company’s scientific advisory board.
  • Dr. Ott is the Clinical Director of the Melanoma Disease Center and the Director, Clinical Sciences, of the Center for Immuno-Oncology at the Dana-Farber Cancer Institute.
  • He joins current scientific advisory board members Dan H. Barouch, M.D., Ph.D., Luke D. Handke, Ph.D., Sachet A. Shukla, Ph.D. and John W. Shiver, Ph.D.
    “We are honored that Dr. Ott has agreed to our scientific advisory board and believe that he will offer invaluable guidance as we further develop our technologies and advance our pipeline,” said Dr. Corinne Le Goff, president and chief executive officer of IMUNON.
  • Dr. Ott has been Principal Investigator of a first-in-human clinical trial testing a personalized vaccine (NeoVax) in patients with melanoma.

LAND Celebrates Milestones and Rust Belt roots with 'Made in Cleveland' Campaign

Retrieved on: 
Tuesday, October 10, 2023

CLEVELAND, Oct. 10, 2023 /PRNewswire/ -- On the heels of selling its 100thCleveland-made electric motorcycle, LAND, an electric mobility manufacturer, announces the launch of its 'Made in Cleveland' campaign, showcasing the company's road to success and deep connection to the Rust Belt region.

Key Points: 
  • "We're committed to designing, building and making our e-motorcycles at our facility in the heart of Cleveland," LAND Founder and CEO Scott Colosimo says.
  • One of the key milestones LAND is celebrating with this campaign is the production of its 100th electric motorcycle that signifies the company's rapid growth and support of Cleveland's economy.
  • In collaboration with Greater Cleveland Partnership, LAND offers an internship program with the goal to encourage young creatives to build their careers in Cleveland.
  • "After they see the design and innovation that's happening here, they start to see that the Midwest is on the rise."

Department of Energy Funds New Center at Argonne for Decarbonization of Steelmaking: Reimagining the Steel Production Process

Retrieved on: 
Friday, September 29, 2023

The U.S. Department of Energy (DOE) recently announced $19 million in funding over four years for DOE’s Argonne National Laboratory to lead the multi-institutional Center for Steel Electrification by Electrosynthesis (C-STEEL).

Key Points: 
  • The U.S. Department of Energy (DOE) recently announced $19 million in funding over four years for DOE’s Argonne National Laboratory to lead the multi-institutional Center for Steel Electrification by Electrosynthesis (C-STEEL).
  • C-STEEL is a key project of the DOE's Industrial Heat Energy Earthshot initiative , which aims to significantly cut emissions from the energy-intensive process of industrial heating.
  • The most energy-intensive step in steel production involves converting iron ore into purified iron metal or iron alloys using blast furnaces.
  • The energy for this process is low enough that it could be provided by renewables or waste heat from a nuclear reactor.

Realeve Unveils Breakthrough Solution to Treat Central Nervous System Disorders Including Stroke and Cluster Headache; Bypasses Brain’s Natural Barrier to Deliver Therapeutics

Retrieved on: 
Thursday, September 21, 2023

Realeve has also been granted Breakthrough Device designation from the FDA with a goal of obtaining FDA approval and CE Mark to treat cluster headaches in 2024.

Key Points: 
  • Realeve has also been granted Breakthrough Device designation from the FDA with a goal of obtaining FDA approval and CE Mark to treat cluster headaches in 2024.
  • We are also exploring its applications in other central nervous system disease conditions and excited about the potential,” states Dr. Peter Bonutti, founder and president, Realeve.
  • This technology holds promise for addressing conditions like Alzheimer's, tumors, and other central nervous system disorders.
  • The targeted therapy provides both pain relief, and can increase blood flow and medication delivery to the central nervous system.

NovoEd Launches LXI: Free Learning Change Management Certification for Executives

Retrieved on: 
Tuesday, September 19, 2023

SAN FRANCISCO, Sept. 19, 2023 /PRNewswire/ -- NovoEd, the leading social and collaborative cohort learning platform, welcomes its first executive participants on Oct. 9, 2023 to LXI: Learning Experience Impact — a new, free certification course designed to help leaders demonstrate and promote the business value of workforce development initiatives at their organizations. LXI follows the LXD: Learning Experience Design course by NovoEd, through which more than 35,000 people from six continents have elevated their skills since 2016.

Key Points: 
  • LXI follows the LXD: Learning Experience Design course by NovoEd, through which more than 35,000 people from six continents have elevated their skills since 2016.
  • NovoEd welcomes its first executive participants on Oct. 9, 2023 to LXI: Learning Experience Impact.
  • Participants who complete LXI will earn the exclusive free change management credential for learning, HR, and talent professionals available today.
  • "In LXI, executives will gain the ability to apply and measure intentional change management techniques to better instigate efficiency, production, and innovation across their companies," said Todd Moran, Chief Strategy Officer of NovoEd.

Randall C. Starling, MD, MPH Receives 2023 HFSA Lifetime Achievement Award for His Contributions to the Field of Heart Failure

Retrieved on: 
Thursday, September 14, 2023

The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.

Key Points: 
  • The award will be presented to Dr. Starling at the HFSA Annual Scientific Meeting on Saturday, October 7 in Cleveland, Ohio.
  • As an internationally recognized pioneer and expert in the field of heart failure, this prestigious award will pay tribute to his exemplary career in heart failure research, publishing, mentorship and leadership.
  • Dr. Starling served as President of HFSA in 2018-2019 and has been an active member since its inception in 1995.
  • Dr. Starling joins an elite list of current and past Lifetime Achievement Award winners with this year's recognition.

Fifth Third Bank Certifies 25 Graduates of its Empowering Community Leaders Program

Retrieved on: 
Tuesday, September 5, 2023

Fifth Third congratulates the 25 community leaders who have completed the Bank’s 18-month Empowering Community Leaders career development growth program.

Key Points: 
  • Fifth Third congratulates the 25 community leaders who have completed the Bank’s 18-month Empowering Community Leaders career development growth program.
  • View the full release here: https://www.businesswire.com/news/home/20230905801694/en/
    The inaugural class of 25 nonprofit leaders graduated from Fifth Third Bank's Empowering Community Leaders program.
  • The 25 graduates are pictured with Fifth Third's Aleta Young, Kala Gibson, Jada Grandy Mock and Katrina Lunsford, pictured from left to right, in the first row.
  • She said, “Fifth Third presented me with such an awesome opportunity to better equip myself to serve my community.

Breast Expert Gregory M. Fedele, MD Joins Exclusive Haute Beauty Network

Retrieved on: 
Wednesday, August 30, 2023

CLEVELAND, Aug. 30, 2023 /PRNewswire-PRWeb/ -- Gregory M. Fedele, MD is a native of the Cleveland area. He attended St. Joseph High School in Cleveland and went on to major in pre-medicine at The University of Dayton, where he earned a Bachelor of Science Degree in Biology and Chemistry. Dr. Fedele attended The University of Cincinnati College of Medicine where his interest in Plastic and Reconstructive Surgery began to grow. Dr. Fedele returned to the Cleveland area for his five years of General Surgery training at Case Western Reserve University, University Hospitals of Cleveland. He then went to The University of Pittsburgh Medical Center, one of the top plastic surgery training centers in the country, for his Plastic and Reconstructive Surgery training. Dr. Fedele remained in the Pittsburgh area in private practice and was a Clinical Assistant Professor of Plastic Surgery at The University of Pittsburgh Medical Center Division of Plastic Surgery.

Key Points: 
  • Gregory M. Fedele, MD joins the Haute Beauty Network as a breast expert representing the Cleveland, OH market.
  • Dr. Fedele attended The University of Cincinnati College of Medicine where his interest in Plastic and Reconstructive Surgery began to grow.
  • Dr. Fedele returned to the Cleveland area for his five years of General Surgery training at Case Western Reserve University, University Hospitals of Cleveland.
  • Dr. Fedele has been awarded Castle Connolly Top Doctors in 2019, 2020, 2021, 2022 & 2023, for Plastic Surgery in Cleveland.

BioAesthetics Welcomes Joseph Nixon to its Board of Directors

Retrieved on: 
Wednesday, August 23, 2023

BioAesthetics Corporation announced today the appointment of Mr. Joseph Nixon to its Board of Directors.

Key Points: 
  • BioAesthetics Corporation announced today the appointment of Mr. Joseph Nixon to its Board of Directors.
  • Mr. Nixon brings over 25 years of life sciences investing and operating experience to BioAesthetics.
  • Nixon brings decades of experiences to BioAesthetics’ Board.
  • “I am excited and honored to join BioAesthetics as a Director,” said Mr. Nixon.

CACI Appoints Stanton D. Sloane to its Board of Directors

Retrieved on: 
Monday, August 21, 2023

CACI International Inc ( NYSE: CACI ) announced today that it has appointed Stanton “Stan” D. Sloane, to its Board of Directors, effective immediately.

Key Points: 
  • CACI International Inc ( NYSE: CACI ) announced today that it has appointed Stanton “Stan” D. Sloane, to its Board of Directors, effective immediately.
  • Sloane will serve as an independent director on the Board.
  • “As a veteran of the aerospace and defense industry for more than 30 years, Stan brings a wealth of knowledge and executive leadership experience to the CACI Board,” said Mike Daniels, Chairman of CACI’s Board of Directors.
  • “He has held seats on three public company boards, and, as a former military officer, he is strongly aligned with CACI’s mission.